In db/db mice, dapagliflozin not only alleviated hyperglycemia but also lowered the expression of GLUT1 and GLUT2, showing that glucose output in hepatocytes was reduced by dapagliflozin. The gene discussed is SLC2A1; the disease is Hyperglycemia.